Our purpose
The Accelerating Clinical Trials in the European Union (ACT EU) initiative will support smarter clinical trials through regulatory, technological and process innovation.
Our vision is to transform the EU into a region that supports clinical trial development and enables collaboration and innovation at all stages of the clinical research lifecycle.
Seamless coordination among stakeholders, regulators and ethics committees will lead to more cross-border collaboration.
The result will be better, more impactful clinical trials, benefitting patients and healthcare in Europe in the process.
Our goal
500 more multi-national trials authorised by 2030
Increased attractiveness of the EU
Progress is measured by monitoring the number of authorised multi-national clinical trials each year.
66% of trials start recruitment in under 200 days from application submission
Faster access to treatment
Progress is measured by monitoring the time from submission of a clinical trial application to the start of patient recruitment at the first Member State concerned.
